Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
224306
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
||
|
NDF-RT |
N0000192703
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
||
|
WHO-ATC |
J06BB22
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
||
|
EU-Orphan Drug |
EU/3/18/2065
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
29Z5DNL48C
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | |||
|
1746906
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | |||
|
m11939
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | |||
|
CHEMBL3544926
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | |||
|
ZZ-114
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | |||
|
100000182406
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | |||
|
8336
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | |||
|
Obiltoxaximab
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | |||
|
C166561
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | |||
|
N0000192702
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | Anthrax Protective Antigen-directed Antibody Interactions [MoA] | ||
|
29Z5DNL48C
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | |||
|
5094
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | |||
|
Obiltoxaximab
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | |||
|
1351337-07-9
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | |||
|
DB05336
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY | |||
|
9825
Created by
admin on Sat Dec 16 09:11:02 GMT 2023 , Edited by admin on Sat Dec 16 09:11:02 GMT 2023
|
PRIMARY |
ACTIVE MOIETY